STOCK TITAN

WISeKey Semiconductors U.S. Patent for a Dual-mode Anti-Counterfeiting IoT Label to be Used in Pharma to Protect Pharmaceuticals Against Counterfeiting

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

WISeKey International Holding Ltd (NASDAQ: WKEY) announced a new IoT anti-counterfeiting TAG, protected by U.S. Patent No. US2019/0114522 A1, aimed at enhancing the security of pharmaceutical products. The TAG can be embedded within packaging, allowing remote verification of authenticity via NFC technology. If tampered, the TAG is damaged, preventing reuse for counterfeiting. This innovation addresses rising concerns over counterfeit medications, which pose significant public health risks. The smart bottle market is projected to grow from $88.6 million in 2016 to $258.8 million by 2024, indicating a growing demand for such secure technologies.

Positive
  • Launch of new anti-counterfeiting IoT TAG addresses public health concerns over counterfeit pharmaceuticals.
  • Successfully acquired U.S. patent provides a competitive edge in the pharmaceutical sector.
  • NFC technology enables efficient tracking and verification throughout the supply chain.
Negative
  • None.

WISeKey Semiconductors U.S. Patent for a Dual-mode Anti-Counterfeiting IoT Label to be Used in Pharma to Protect Pharmaceuticals Against Counterfeiting

A full description link to patent is available at https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20190114522

Geneva, Switzerland/New York, USA – February 28, 2023 – WISeKey International Holding Ltd (“WISeKey”), (SIX: WIHN; NASDAQ: WKEY) a cybersecurity IoT platform company, today announced that it has develop a new IoT anti-counterfeiting TAG based on its U.S. patent. Pub No. US2019/0114522 A1 https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20190114522

The TAG is designed and strategically placed inside the pharmaceutical package including bottles and containers used to package and ship medications. When the device is intact, it can be interrogated remotely by an NFC reader to retrieve information on the product, and also to confirm the authenticity of the information. When the package is opened the NFC TAG is damaged, so that the package cannot be reused to authenticate a fake pharmaceutical product. The technologically wireless communication capabilities for connecting with computing devices such as smartphones or wearables and an artificial memory that helps provide alerts through display or sound system. With applications presently spanning across pharmaceutical products anti-counterfeiting tags are increasingly gaining traction and are observing vast developments in terms of innovation and technological advances.

Carlos Moreira, WISeKey’s CEO, noted, “WISeKey’s NFC tags can help protect against counterfeiting by providing a way to authenticate products and our U.S. patent provides pharmaceutical companies with a much-needed solution to put a stop to distribution of counterfeit medications, a huge threat to public health. When an NFC-enabled smartphone or device is brought close to an NFC tag, the tag can transmit information to the device, such as a unique identifier for the product. NFC tags can also be used to track the product through the supply chain, from the manufacturer to the distributor to the retailer. This can help prevent counterfeit products from entering the supply chain in the first place and can also help identify the source of any counterfeit products that are discovered.”
Overall, NFC tags provide a simple and effective way to authenticate pharmaceutical products and protect against counterfeiting, which can help ensure that consumers receive safe and effective medications.

Transparency Market Research estimates that the global smart bottle market, which was pegged at US$88.6 million in 2016, will reach US$258.8 million by 2024, registering a CAGR of 14.3% between 2016 and 2024.

Near Field Communication (NFC) technology is a wireless communication technology that enables two devices to communicate with each other when they are in close proximity. An NFC tag is a small electronic device that can be embedded in a product or attached to its packaging to store information.
Pharmaceutical products are often the target of counterfeiting, where fake drugs are sold to consumers under the guise of genuine products. This can have serious health consequences, as counterfeit drugs may not contain the correct ingredients, or may be contaminated with harmful substances.

This unique identifier can then be used to verify the authenticity of the product by checking it against a database of valid identifiers maintained by the manufacturer or a third-party authentication service. If the identifier is not found in the database or is found to be invalid, it is likely that the product is a counterfeit.

WISeKey IoT Tags offers the only solution that is based upon Common Criteria (EAL4+) for object identification and FIPS 140-2, meaning the solution provides the same level of digital security trusted by banks, the U.S. Department of Defense and l’ANSSI in France.   WISekey has also filed a new patent in Switzerland and U.S. that ensures the provenance, authenticity, persistence, and long-term value of NFTs that are minted on Blockchains using this method. During the minting process, this method allows to ensure that the NFT is not corrupted, incomplete, or ambiguous.

In general, there is a high confidence in the ability of a Blockchain to preserve and store the public key and digital signature information of the NFT along with any subsequent transaction data over long and very long periods of time. However, a Blockchain cannot preserve information that the NFT does not itself include. Such as disclosed in the patent application, it is the information in a persistent off-chain storage that establishes the value and that needs to be authenticated and secured.

NFTs that are not created by this method will not contain enough information to ensure that the minter of the NFT was the originator or possessor of the object at the time of minting or had authority to mint the NFT. Without identifying and establishing the rights of the minter, the long-term value of the NFT is diminished.

The information associated with an NFT can easily degrade over long periods of time. For example, over several decades or even over centuries the owner of an NFT, their descendants, and others may find it difficult to discern whether an NFT is authentic or what object the NFT is associated with, or the location where the object itself is located. There is no assurance that the NFT itself will preserve its ability to authenticate the associated object or that its association with the object will be preserved.

In order to solve these technical problems, the methods protected by the patent application define the structure, composition and minting process of an authenticatable and persistent NFT to establish and maintain long-term value as well as corresponding systems implementing these methods.

WISeKey has aggregated over 46 IoT patent families (more than 200 patents in total) to its portfolio (https://www.wisekey.com/patents/) required to power the WISeKey IoT Platform. For WISeKey, adding to its patent portfolio and intellectual property is key to ensuring that the company will remain a major player in the IoT Industry for years to come as company focuses on integrating unique technology that is differentiated, protected and hard to reproduce based on tangible scientific discoveries or engineering innovations.

The IoT Industry is a game changer new business segment for WISeKey.  An estimated 50 billion IoT devices are expected to be connected by 2020, while world’s population is estimated to grow to 6.8 billion; thus, there will be more than 7 IoT devices per person connected to the internet by 2020. As a result, it is anticipated that this year already the number of IoT devices will surpass the number of mobile devices. By 2021, it is expected 1.8 billion PCs, 8.6 billion mobile devices, and 15.7 billion IoT devices; by 2035, the amount of data usage is expected to grow more than 2,400 times, from 1 exabyte to 2.3 zettabytes. 

A huge and increasing amount of sensitive data that will need to be protected by the IoT chips produced by WISeKey will be interchanged between connected devices and back-end servers, allowing companies to provide users with new type of applications. These applications will be designed to offer increased control over the use of resources, improve efficiency in power grids, optimize processing of information in industrial environments, secure autonomous vehicles, provide better and higher quality healthcare services and personalized experience for shopping or leisure, among others.

About WISeKey
WISeKey, founded in 1999 (NASDAQ: WKEY; SIX Swiss Exchange: WIHN), is a leading global cybersecurity company currently deploying large scale digital identity ecosystems for people and objects using Blockchain, AI and IoT respecting the Human as the Fulcrum of the Internet. WISeKey microprocessors secure the pervasive computing shaping today’s Internet of Everything. WISeKey IoT has an install base of over 1.5 billion microchips in virtually all IoT sectors (connected cars, smart cities, drones, agricultural sensors, anti-counterfeiting, smart lighting, servers, computers, mobile phones, crypto tokens etc.). WISeKey is uniquely positioned to be at the edge of IoT as our semiconductors produce a huge amount of Big Data that, when analyzed with Artificial Intelligence (AI), can help industrial applications to predict the failure of their equipment before it happens.

Our technology is Trusted by the OISTE/WISeKey’s Swiss based cryptographic Root of Trust (“RoT”) provides secure authentication and identification, in both physical and virtual environments, for the Internet of Things, Blockchain and Artificial Intelligence. The WISeKey RoT serves as a common trust anchor to ensure the integrity of online transactions among objects and between objects and people. For more information, visit www.wisekey.com.

Press and investor contacts:
WISeKey International Holding Ltd
Carlos Moreira
Chairman & CEO
+41 22 594 3000 / info@wisekey.com

WISeKey Investor Relations (US)
The Equity Group Inc.
Lena Cati
212 836-9611 / lcati@equityny.com
Val Ferraro
212 836-9633 / vferraro@equityny.com

Disclaimer:
This communication expressly or implicitly contains certain forward-looking statements concerning WISeKey International Holding Ltd and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of WISeKey International Holding Ltd to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. WISeKey International Holding Ltd is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

This press release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, and it does not constitute an offering prospectus within the meaning of article 652a or article 1156 of the Swiss Code of Obligations or a listing prospectus within the meaning of the listing rules of the SIX Swiss Exchange. Investors must rely on their own evaluation of WISeKey and its securities, including the merits and risks involved. Nothing contained herein is, or shall be relied on as, a promise or representation as to the future performance of WISeKey.


FAQ

What is WISeKey's new anti-counterfeiting IoT TAG about?

WISeKey's new TAG is designed to enhance the security of pharmaceutical products by allowing remote authentication via NFC technology.

What patent is associated with WISeKey's new IoT TAG?

The TAG is protected by U.S. Patent No. US2019/0114522 A1.

How does the anti-counterfeiting TAG work?

The TAG, embedded in packaging, can be interrogated remotely to verify product authenticity, and it is damaged if tampered with.

How significant is the counterfeit medication issue?

Counterfeit drugs pose serious health risks, potentially containing incorrect ingredients or harmful substances.

What is the market potential for smart bottles?

The smart bottle market is projected to grow to $258.8 million by 2024, indicating strong demand for anti-counterfeiting solutions.

WISeKey International Holding AG American Depositary Shares

NASDAQ:WKEY

WKEY Rankings

WKEY Latest News

WKEY Stock Data

18.80M
9.79M
0.89%
0.15%
Semiconductors
Technology
Link
United States of America
Zug